Innovation

Sutter Roseville Moves Up Opening of ER-ICU Expansion to Prepare for COVID-19 Patient Surge

Posted on Apr 27, 2020 in Expanding Access, Innovation, Quality, Safety, Scroll Images, Sutter Roseville Medical Center, Transformation

Sutter Roseville Medical Center expansion
Sutter Roseville Medical Center is opening its expansion a month early to prepare for a potential surge in COVID-19 patients.

ROSEVILLE, Calif. – Sutter Roseville Medical Center on Tuesday, April 28, is opening its expansion of emergency and critical care services a month early as part of its preparations for a potential surge of COVID-19 patients. Originally slated to open May 27, the 98,400-square-foot expansion doubles the Emergency Department and nearly doubles the number of critical-care beds, adding 58 more private rooms that can safely care for patients during a possible surge.

Sutter Roseville began the $178 million construction project in 2017 to meet the growing community’s demand for emergency services, critical-care rooms and interventional cardiac and neuro procedures. It is connected seamlessly to the existing Emergency Department on the first floor and surgical and critical care services on the second.

“When our team met in late February to discuss surge preparations for COVID-19, it was apparent that we needed to move up the opening of this expansion to ensure we had the highest level of care available for the expanding needs of our community and region,” said Sutter Roseville CEO Brian Alexander. “Our staff, construction partners, and state and local agencies all banded together and worked diligently to open this expansion 30 days early, but to the same high safety and quality standards.”

As a Level II trauma center serving a seven-county region, Sutter Roseville provides a higher level of care in emergency situations and is regularly preparing for public health crises. The expansion was designed with elements that will assist in those emergencies, including two emerging infectious disease isolation rooms and options to convert the Emergency Department’s expansive lobby into a treatment area in case of a large-scale disaster or patient surge.

Expanded emergency department looby

“When our care teams helped design this expansion, they took into account numerous possible health-crisis scenarios,” Alexander said. “Because of their foresight and planning, Sutter Roseville is prepared to care for patients during this pandemic and other public-health emergencies.”

The new expansion helps Sutter Roseville stay on the forefront of exceptional, innovative care. Its features include:

  • 34 additional emergency beds in private treatment rooms, increasing the total number of emergency beds to 68;
  • Seven emergency triage areas that are equipped to provide treatment to patients;
  • 24 additional ICU rooms, each equipped with the latest eICU telemonitoring capabilities that allow specialized physicians to assist in the care of the patients from a remote hub. Added to the 32 existing critical-care beds in the hospital, there will be 56 ICU rooms available for the sickest patients if a surge were to occur;
  • Two interventional labs providing the latest technology for cardiac catheterization procedures. A third interventional lab is currently being built with additional capabilities for neuro and radiological procedures.
New intensive care unit room

“California is being challenged in new ways during the COVID-19 public health crisis, and we are rising to that challenge in ways large and small across the state,” said California State Sen. Jim Nielsen, R-Tehama. “Here in Northern California, one of the organizations stepping up to meet the challenge is the Sutter Health network, providing new levels of emergency and critical care at Sutter Roseville Medical Center that are so urgently needed across the region.”

The expansion provides a critical need in the community beyond the current global pandemic crisis. The Sutter Roseville Emergency Department expanded in 2005 to treat up to 60,000 patients a year, but last year saw more than 84,000 patients. The additional ICU rooms and interventional labs are also necessary additions as South Placer County is seeing more elderly patients requiring a higher-level of care.

Emergency department isolation room

“Strong infrastructure is one of the hallmarks of a strong community, and our capacity for protecting and promoting public health is central to that,” said State Assemblyman Kevin Kiley, R-Rocklin. “Sutter Roseville Medical Center’s continued investment in our public health infrastructure helps drive our ability to prevent disease, heal after injury or illness, and respond to both chronic health challenges and acute ones like COVID-19. My thanks to Sutter Health for stepping up to help when and where they are needed.”

This is the latest in a series of expansions Sutter Roseville Medical Center has experienced in the past two decades, transforming it from a community hospital into a regional, tertiary medical campus. The other expansions include:

  • A newly constructed Patient Care Tower with 90 new beds.
  • Expansion of the Family Birth Center to accommodate a community need as young families moved into South Placer County.
  • The addition of a Level III NICU with 16 licensed beds to provide advanced life-saving care to critically ill newborns.
  • The construction and expansion of Sutter Rehabilitation Institute, the region’s only facility dedicated exclusively to acute rehabilitation services.
  • The Sutter Cancer Center, Roseville, a facility dedicated to and designed by those with cancer.
  • Three medical office buildings that house Sutter Roseville physicians, along with two parking garages for staff and patients.

“As a healthcare provider, as an employer and as a supporter of this community, Sutter Roseville Medical Center has already been a strong force for good here and across Placer County and the region,” said Roseville Mayor John Allard. “Expanding its top-notch emergency service and critical care – especially now – builds on a decades-long commitment to serving the people of Roseville and beyond.”

COVID-19 Heightens our Love for Mother Earth, and One Another

Posted on Apr 22, 2020 in Community Benefit, Innovation, People, Quality, Safety, Scroll Images, Transformation, Uncategorized

A message from Stephen H. Lockhart, M.D., Ph.D., Sutter Health Chief Medical Officer and Executive Sponsor of Sutter Health’s Environmental Stewardship Program

With fewer cars on the road and less traffic in the skies, some news outlets have reported a climate benefit. While none of us wanted this short-term positive effect at such high health and economic costs, we are getting a peek at an environment with less human interference — a brief glimpse at what could be possible if we took steps to reduce waste and advance alternative energy solutions in the years ahead.

As champions of health, we know that nature holds a special place in our lives, supporting our mental and physical wellbeing. It’s never been more important to take a walk outside, take a deep breath, enjoy the sunshine and wave at our neighbors — all while staying 6 feet apart, of course. Nature lifts our spirits and helps restore our hope.

Please join our Sutter team in celebrating the 50th anniversary of Earth Day. Mobilizing to care for our planet over the long term is one more way we’re showing our love for our communities and one another.

Here are a few ways you and your family can get involved with Sutter’s sustainability efforts:

1. Plant a garden. Digging your hands in the soil is good for your health. Welcome spring by planting native plants, fruits and vegetables. Take it a step further by starting a compost pile. Composting food waste reduces the amount of waste you send to a landfill, and once it fully decomposes, you’re left with a fertilizer for your garden. Check out some simple tips on composting from the EPA.

2. Donate clothing. While spring cleaning, consider donating unwanted items rather than throwing them away. Each year, nearly 40,000 gallons of water are used in the production and transport of new clothes bought by the average American household.

3. Watch creativity grow. Promote your kids’ love for our planet by encouraging them to create art from natural or recycled materials.

4. Conserve water. Install a low-flow shower head to reduce water use. In one year, a family of four can save up to 18,200 gallons of water.

5. Carry a reusable water bottle. Lessen your environmental impact by replacing your single-use plastic bottles with a stainless-steel water bottle or travel mug.

6. Calculate your carbon footprint. Simply reducing the amount of time we spend running errands, driving to work and to other activities plays a significant role in reducing our carbon footprint. Check out the EPA’s Carbon Footprint Calculator.

7. Learn about sustainability efforts at Sutter Health. Did you know that Sutter completed five solar-power projects; launched a pilot program to reduce the amount of harmful anesthetic gasses released into the atmosphere during surgeries; and increased plant-based meals by 20% in our 24 hospital cafeterias? You can find out more here.

A Higher IQ for Cancer Care at Sutter

Posted on Apr 20, 2020 in California Pacific Medical Center, Innovation, People, Quality, Research, Transformation

Machine learning for cancer research

To learn how Sutter cancer researchers are applying machine learning to cancer care, we interviewed John Chan, M.D., a gynecologic oncologist at Sutter’s California Pacific Medical Center (CPMC) and Palo Alto Medical Foundation, and the Denise & Prentis Cobb Hale Endowed Chair in Gynecologic Oncology Research.

John Chan, M.D.

How might artificial intelligence (AI) be used to improve cancer care?
AI builds smart machines capable of performing tasks that typically require human intelligence like learning, reasoning and problem-solving skills. We already see AI playing a key role in our daily routines and our interactions with media, transportation and communications.

With a surge of new knowledge in this area, researchers are applying AI and machine learning to innovate healthcare with improved diagnoses and treatment. As machine learning algorithms are exposed to more data—in some cases gleaned from the electronic heath record (EHR)—they can detect hidden patterns within data that can be used to perform a task without sophisticated programming.

Given the large number of Americans diagnosed with cancer and the huge volume of data generated during cancer treatment, there is a growing interest in using AI and machine learning to improve cancer care.

How are you applying AI and machine learning to your gynecologic oncology practice at Sutter?
Through a collaboration with the University of North Carolina and The Medical College of Georgia at Augusta University, we’re using machine learning to classify cancer patients into high- or low-risk groups, and to personalize sub-groups of uterine cancer patients who may or may not benefit from chemotherapy. Our research resulted in a clinical calculator that was described in Gynecologic Oncology.

The findings suggest a clinical calculator can help predict benefit and risk of chemotherapy treatment in patients with uterine cancer. And now we’re expanding the machine learning tool to study advanced-stage cancers and gynecologic diseases like ovarian cancer.

We plan to share the clinical calculator with providers across Sutter and with peer institutions that care for gynecologic cancer patients who live in more remote communities, or who are otherwise unable to travel to larger cancer centers. That way, more cancer patients may benefit from the research underlying this new AI-based tool. This could help increase access to safer and more effective cancer treatments, and reduce healthcare costs.

What are the potential benefits of using AI and machine learning to guide oncology treatment decisions?
Machine learning can “free think” creatively because it’s not confined by pre-existing human biases that may be present in routine clinical practice. This and other AI approaches like deep learning can help us determine levels of risk and benefit associated with various cancer treatments.

For example, an older patient with ovarian cancer may be at increased risk of treatment-related complications compared with younger patients. AI can identify risk profiles to help guide treatment decisions based on data from similar sub-groups of cancer patients.

In clinical oncology, AI has increasingly been applied to harness the power of the EHR. Specifically, AI-based natural language processing techniques may help predict the development of diseases across large healthcare systems.

At Sutter, our integrated network enables access to EHR and outcomes data from a highly diverse patient base. Machine learning can find associations and calculate risk scores to better predict treatments that will provide optimal benefit and reduced risk of treatment-related complications or adverse effects. This approach may become a new decision tool that we can add to our clinical toolkit and share with collaborators across Sutter.

Cancer care and research at Sutter: High “CQ” using machine learning:

Other Sutter physicians, researchers, and innovators across the system are applying AI to cancer care and elsewhere. Here’s how:

  • Earlier this year, Sutter partnered with Bay Area startup Ferrum Health to develop machine learning algorithms for early detection of lung cancer at radiology clinics in Sacramento. Ferrum’s AI platform read 10,000 CT scans and reports. Within 90 days, it flagged 83 cases in which it detected a mass of tissue on the scan that was not mentioned in the report.
  • Albert Chan, M.D., M.S., Sutter Health chief of digital patient experience, is leading digital transformation efforts across Sutter. He oversees a unified digital patient engagement and virtual care strategy, including leadership of Sutter’s patient portal My Health Online, telemedicine and artificial intelligence-powered solutions.
  • Through a collaboration with Stanford Medicine, Sutter Health systems researchers will launch the Oncoshare Project using a “big data” approach to improve breast cancer care. Oncoshare enables researchers to generate high-resolution maps of breast cancer treatment, and identify care pathways that yield the best outcomes for patients.

Learn more about Sutter research and clinical trials.

The Digital Doctor Is In: Healthcare Services You Can Access at Home

Posted on Apr 17, 2020 in Carousel, Innovation, Palo Alto Medical Foundation, Scroll Images, Uncategorized, We're Awesome

SACRAMENTO, Calif. – Receiving sound medical advice is more important now than it’s ever been. Albert Chan, M.D., chief of digital patient experience at Sutter Health, shares how you can get advice and take action, all from your living room.

Dr. Chan answers questions from Sutter Health staff in the Q&A below.

Search Your Symptoms

Q: Google has reported a surge in searches related to COVID-19. Are search engines able to give results that can help real people get the counseling and care that they need right now?

Albert Chan, M.D., Sutter Health’s
chief of digital patient experience

A: Many people who develop a fever, shortness of breath, or cough right now may be concerned that they have COVID-19. While Google, WebMD and other online tools are good at providing general guidance, they can’t suggest concrete care options, because they aren’t connected to a group of medical providers.

Sutter Health’s online Symptom Checker is a little different. After entering your brief medical history and current symptoms, you will receive a personalized health assessment and can then enter your location to find nearby care options offered by the Sutter Health network.

Originally launched in February 2019, I see the Symptom Checker as a way to help patients decide whether to engage in self-care or to seek care, if they need an in-person appointment or a video visit, and if they need to be seen now or soon. These distinctions are incredibly apt as we face the COVID-19 outbreak, concurrent with flu and allergy seasons. I’m proud that the Symptom Checker has been updated to recognize a possible COVID-19 infection, and guide patients appropriately.

Turn to the Telephone

Q: Having a trusted source of information and the ability to talk through your symptoms is desperately needed right now — what is available to the public?

A: The public has a few options, one of which is the Sutter Health COVID-19 Advice Line at 1-866-961-2889.

Staffed by a team of nurses from 8 a.m. – 6 p.m., seven days a week, every caller is screened for symptoms linked to coronavirus. Callers are then directed to the most appropriate level of care, including self-care at home for those with mild symptoms.

Please note: The COVID-19 Advice Line is intended for people who are ill or caring for someone who is ill. For general information about coronavirus, please refer to the Centers for Disease Control and Prevention (CDC) website. The COVID-19 Advice Line is not for emergency situations. If you think you are experiencing a medical emergency, please call 911 or visit the nearest emergency room.

Seeing is Believing

Q: Some things are hard to diagnose or make decisions about over the phone, what other options are available for patients?

A: Patients can get virtual care from their phone, tablet or computer through Sutter Video Visits. This video gives you a sense of the video visit experience.

We offer a couple of options:

Video visits are expanding to address many primary and specialty care needs. Patients can now call or message their care team via My Health Online to check the availability of video visit appointments with their clinicians.

If you have not yet enrolled in My Health Online, you can now sign up online.

We also offer same-day video visits with our Sutter Walk-In Care clinicians daily from 8 AM to 8 PM for common health issues. Patients can self-schedule a video visit appointment by logging into My Health Online or calling (800) 972-5547 for same-day appointments.

Currently we are conducting virtual assessment of respiratory symptoms daily, which provides both convenient access to care to patients at home and minimizes the risk of spreading illness to others. These video visits can also provide clinicians with the information necessary to decide if a patient ultimately needs to be seen in person at one of our clinics or the hospital.

For more information about COVID-19, please visit Sutter Health’s resources page.

How a Pandemic Launched a NorCal Healthcare System

Posted on Apr 14, 2020 in Carousel, Community Benefit, Expanding Access, Innovation, People, Quality, Scroll Images, Sutter Medical Center, Sacramento, Transformation, Uncategorized

Spanish Flu
A nurse takes a patient’s pulse in the influenza ward at Walter Reed Hospital in Washington, D.C., on Nov. 1, 1918. Photo courtesy of Library of Congress.

The pandemic started slowly in Sacramento. For weeks, residents of the city believed what was going around was just the usual flu that arrived every fall. But in just two months, thousands in the city had been infected and about 500 Sacramentans were dead.

That happened a century ago. Because of the inadequacy of the existing Sacramento hospitals to care for the numerous victims of the Spanish flu in 1918, local doctors and civic leaders banded together to build a new, more modern hospital to meet the growing city’s needs.

Sutter Health was born.

Begun as a single Sutter Hospital kitty-corner to Sutter’s Fort, Sutter Health now has a presence in 22 counties across Northern California, featuring thousands of doctors and allied clinical providers and more than 50,000 employees. As an integrated health system, Sutter is uniquely qualified and capable to care for residents during a health crisis such as COVID-19.

“A group of hospitals and doctor’s offices are able to band together, share resources, skills and knowledge, and institute best practices to care more effectively and efficiently for our patients and the communities we serve,” said Dave Cheney, the interim president and CEO of Sutter Valley Area Hospitals and the CEO of Sutter Medical Center, Sacramento. “We have systems in place that we test all the time to ensure we are prepared for many crises, including a pandemic like COVID-19.”

Groudbreaking
Just a few years after the devastating Spanish flu, Sacramento physicians, nurses and civic leaders gathered to break ground in 1922 for the first Sutter Hospital.

Physicians Fill a Need in Sacramento

The deadly influenza commonly called Spanish flu killed about 50 million worldwide. From August 1918 to July 1919, 20 million Americans became sick and more than 500,000 died, 13,340 of them in California. In Sacramento, slow action by the city public health office delayed care and, within a couple of weeks, sick residents flooded the hospitals. The city library was even converted into a makeshift hospital. A Sutter Medical Center, Sacramento history recounts: 

“The influenza epidemic of 1918 gave convincing evidence to Sacramento doctors that the city’s two major hospitals were woefully inadequate to provide the health care services vital to the rapidly growing community. The flu epidemic had sorely taxed these facilities and highlighted the need for a modern, fireproof hospital. Recognizing the critical need for hospital care for their patients, 17 local physicians came together with civic leaders to create a new hospital.”

The group incorporated as Sutter Hospital Association in 1921, naming it after its neighbor, Sutter’s Fort, which cared for Gold Rush pioneers as Sacramento’s first hospital. The first Sutter Hospital was built two years later and opened in December 1923 as “the most modern hospital to be found in the state,” according to The Sacramento Bee. It was the first private, non-sectarian hospital in the city, and the first to offer private rooms.

The hospital became not-for-profit in 1935 and changed its name to Sutter General Hospital. It opened Sutter Maternity Hospital in 1937 two miles away and it soon expanded its services and was renamed Sutter Memorial Hospital. In the 1980s, the old Sutter General Hospital was replaced by a modern facility across the street from Sutter’s Fort, and in 2015 all adult and pediatric services were combined under one roof when the Anderson Lucchetti Women’s and Children’s Center opened essentially in the same location as the original Sutter Hospital.

First Sutter Hospital
The first Sutter Hospital opened in December 1923 as California’s “most modern hospital.” Now, Sutter Health is an integrated healthcare system that includes 24 hospitals in Northern California.

A Health Network Grows

The 1980s and 1990s saw tremendous growth for Sutter. Struggling community hospitals in Roseville, Auburn, Jackson, Davis, Modesto and other nearby cities merged with what was then known as Sutter Community Hospitals. Then came the deal that more than doubled the healthcare system. In 1996, Sutter Community Hospitals merged with a group of Bay Area hospitals and physician groups known as California Healthcare System. These included such large, well-respected, historic hospitals as California Pacific Medical Center in San Francisco and Alta Bates in the East Bay. This new system became, simply, Sutter Health.

Now as a model of healthcare integration, Sutter Health provides a user-friendly system centered around patient care — a system that offers greater access to quality healthcare while holding the line on costs. This connectivity allows Sutter teams to provide innovative, high-quality and life-saving care to more than 3 million Californians. Sutter’s integrated care model allows care teams and care locations to use the power of the network to share ideas, technologies and best practices, ultimately providing better care and a user-friendly experience, achieving healthier patient outcomes and reducing costs.

Our Heroes Wear Scrubs
Grateful community members are thanking Sutter Health front-line workers throughout Northern California.

An Integrated Network Fights COVID-19

Today, Sutter Health’s hospitals and physician groups don’t operate in a vacuum. Each hospital is supported by a larger system that can share knowledge and send materials, equipment and even manpower to where they are needed most. The system is called the Sutter Health Emergency Management System, which is organized after the federal government’s National Incident Command System.

Here’s how it works: Part of the Sutter Health Emergency Management System is a team throughout the network that works on gathering and purchasing the necessary supplies and equipment needed during this pandemic, including N95 masks and ventilators. Another team monitors bed space to ensure that each hospital can care for a COVID-19 patient surge. Clinical team members across the network are working together to address any issues that may unfold and to share best practices as they treat coronavirus patients.

That’s the power of a not-for-profit, integrated healthcare network.

“We are leveraging the strength of our united teams to increase our capacity and knowledge, and to provide the necessary equipment,” Cheney said. “We are preparing all of our network hospitals in the event we see a surge in patients due to COVID-19. Thanks to the integrated system that has been more than 100 years in the making, we are prepared for a pandemic of this magnitude now more than ever.”

Could an Experimental Drug Studied for Ebola Work Against COVID-19?

Posted on Apr 8, 2020 in Affiliates, California Pacific Medical Center, Community Benefit, Expanding Access, Innovation, Quality, Research, Scroll Images, Sutter Medical Center of Santa Rosa, Sutter Santa Rosa Regional Hospital

Not-for-profit Sutter Health Launches Clinical Trials with Gilead Sciences

clinical trials for Covid-19

Sutter Health, together with health systems across Northern California has teamed up with Foster City-based Gilead Sciences on clinical trials for a promising treatment for COVID-19. The COVID-19 vaccine is at least a year away and now scientists across the globe are investigating existing medicines that might work as treatments.

In April 2020, Sutter began participating in two of Gilead Sciences’ Phase 3, randomized clinical trials to evaluate the use of the company’s drug, remdesivir, in adults diagnosed with COVID-19, the disease caused by the novel coronavirus.

The studies test the clinical efficacy and safety of remdesivir in patients with moderate or severe COVID-19, compared with standard-of-care treatment. The U.S. Food and Drug Administration (FDA) reviews results from Phase 3 trials when considering a drug approval.

Promising Treatment
Remdesivir is an antiviral, intravenous drug made by Gilead Sciences. It’s been available as an experimental compound for years, but has not been approved by the FDA for use in clinical treatment.

Jamey Schmidt, Director of Clinical Research at Sutter’s California Pacific Medical Center (CPMC), quickly saw the potential benefit to patients in partnering drug manufacturers (in this case, Gilead Sciences) with Sutter researchers and physicians skilled in clinical trial start-up and ready to help tackle the infectious disease outbreak.

“Sutter research is committed to bring this investigational treatment to Sutter physicians caring for patients infected with the novel coronavirus,” says Schmidt, who collaborated with Greg Tranah, Ph.D., CPMC’s Scientific Director, and Jennifer Ling, M.D., infectious disease specialist at CPMC and principal investigator of the remdesivir clinical trials at CPMC.

CPMC, Sutter Santa Rosa Regional Hospital, Sutter Roseville Medical Center and Sutter Medical Center Sacramento are participating in the clinical trials of remdesivir, and other Sutter sites may enroll to the studies later this month.

“In response to this global health crisis, we’re proud that Sutter is helping lead efforts across Northern California and seeking new tools to combat this novel infection and lessen the virus’s impact,” says Dr. Ling. “Through research at Sutter, new discoveries will help determine the potential of remdesivir to help individual patients with COVID-19.”

Some patients who have been infected by the novel coronavirus and are severely ill may not meet the study criteria for enrollment in the clinical trials of remdesivir. Instead, they may qualify for treatment via Gilead Sciences’ expanded access program (EAP) for remdesivir. The EAP provides alternative access to the investigational drug for severely ill patients with COVID-19 who do not meet the clinical trials study criteria.

First developed in 2009 and used during the Ebola outbreak in 2014, remdesivir is being studied in multiple clinical trials worldwide to see if it is safe and effective against the coronavirus in humans. The drug was previously tested in animals infected by other coronaviruses like SARS and MERS, and is now being tested in humans to determine if it can reduce the intensity and duration of COVID-19.

“Research at Sutter is helping deliver safe, high-quality care to our patients during this unprecedented pandemic,” says Leon Clark, Vice President, Chief Research and Health Equity Officer, Sutter Health. “By bringing innovation to the forefront of how we can best care for Sutter patients who acquire COVID-19, Sutter’s talented researchers are stepping up to the challenge presented by this global health crisis.”

April 29 Update:
Results from a clinical trial of remdesivir, an antiviral manufactured by Gilead Sciences, led by the U.S. National Institutes of Health (NIH) were reported April 29, 2020. The findings suggest that hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, was the first clinical trial launched in the United States to evaluate remdesivir as an experimental treatment for COVID-19.

Additionally, Gilead Sciences also shared preliminary results today from the company’s open-label, Phase 3 SIMPLE trial evaluating five- and 10-day dosing durations of remdesivir in hospitalized patients with severe COVID-19. The study results demonstrated that patients receiving a 10-day treatment course of remdesivir achieved similar improvement in clinical status compared with those patients who were administered a five-day treatment course of the drug.

Sutter is not participating in the ACTT treatment trial nor the SIMPLE clinical trial. However, as described in the above article posted on April 8, Sutter is participating in the two Phase 3, randomized, controlled clinical trials that are testing remdesivir. Gilead Sciences has not yet disclosed when results of these clinical trials will be published. Clinical trials at Sutter testing investigational use of remdesivir will close to enrollment May 29, 2020.

May 4 Update:
On May 1, 2020, remdesivir received FDA Emergency Use Authorization for the treatment of COVID-19. The authorization enables the potential use of remdesivir to treat hospitalized patients suffering from severe COVID-19 disease in the U.S., outside of the context of an established clinical trial of the drug. Based on patients’ severity of disease, the authorization allows for five- and 10-day treatment durations.

Learn more about Sutter research and clinical trials.